Lebrikizumab in Moderate-to-severe Atopic Dermatitis

Clinical trial NCT06906497 · RECRUITING

Trial details

NCT number: NCT06906497
Sponsor: Johann E Gudjonsson MD PhD
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2025-07-02
Primary completion: 2027-07-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.